Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 276-300 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
manifestations and laboratory findings of patients with Covid-19.
Design:
Double blind, randomized clinical trial, with control group, with a parallel group design of 90 patients with Covid-19.
Settings and (...) patients with Covid-19
Criteria:patients of COVID-19 with positivepolymerase chain reaction (PCR) test;Lack of hospitalization indication (...) hyperimmune bovine milk and colostrum will be orally tested on a group of referral COVID-19 patients to PCR (...) Study aim:
Comparison of the Effectiveness of COVID-19specific antibody in hyperimmune bovine milk
Study aim:
The effect of pentaglobin on patients with coronavirus
Design:
covid-19patients (...) exclusion criteria:
Non-intubated patients
Positive covid patients
Patients over 18 years of age
Intervention groups:
covid-19patients admitted to the intensive care unit and who had severe respiratory
findings and inflammatory markers in patients with Covid19
Design:
Clinical trial with control group (...) conduct:
setting of study is Family hospital of army .In this study, 200 newly diagnosed COVID-19(...) PCR for Covid19 2. Existence of at least two of the following findings: RR>20, SO2<93%, GGO>10
with Covid-19
Design:
The randomized double-blind clinical trial, with parallel design in phase 3 (...) will be performed on adult patients (aged 18 to 75 years) with a definitive diagnosis of COVID-19(...) treatment of Covid19 disease in the outpatient and inpatient services of the Ministry of Health and Medical
Study aim:
The effect of olfactory training on anosmia following COVID-19 infection
Design:
Patients between the ages of 18-60 years following COVID-19 infection with olfactory dysfunction and a (...) and exclusion criteria:
Inclusion Criteria:
Patients between 18-60 years old following COVID-19
hospitalized patients with moderate to severe COVID-19.
Design:
This is a parallel 2-arm randomized (...) criteria:
All moderate to severe COVID-19 infected patients admitted to Ema Reza hospital (Mashhad (...) moderate to severe COVID-19 in a 1:1 ratio: • Combination of traditional medicine+standard treatment
Covid-19 admitted to critical care unit
Design:
The study will be double blind and clinical trial.64 (...) and conduct:
Patients with Covid-19 with moderate disease severity (with Apache score above 25 (...) criteria:Suffering Covid-19 without intubation, apache less than 25,
28 to 75 years, absence of acute asthma, absence
Study aim:
Study the effect of Favipiravir on the outpatient treatment Covid-19 patients
Design:
70 outpatient patients with covid-19 will be randomly assigned to intervention and control (placebo (...) criteria: definite case of Covid-19, age over 18, presented within 5 days from the start of sign and
) supplement on COVID-19 disease's outcomes (consisted of laboratory measures ; ventilator free days;) LOS ICU (...) group, randomization using Random Number Table, phase 2 on patients with COVID-19
Settings and conduct:
The study will be carried out among COVID-19 patients admitted in ICU hospitals. Spirulina supplement
symptoms of patients with mild COVID-19
Design:
This study is a single-center, prospective, randomized (...)COVID-19; Confirmed diagnosis of COVID-19, with RT-PCR confirmation; Less than 7 days have passed since (...) Qovid-19 referred to Baqiyatallah Hospital who are eligible for the study are randomly divided into
overload caused by COVID-19 viral infection.
Design:
In this study, the intervention, which is done as a randomized clinical trial, selected 78 patients with covid19 virus who were randomly assigned to two groups (...) :
People with COVID19 are referred to the Corona ward in Shohada Tajrish Hospital and are treated with
Study aim:
Investigation of effect of pulsed ultrasound on smell disorder in recovered patients of COVID19
getting better of variable of smell disorder in recovered patients of COVID19 based on IRAN (...)
Participants/Inclusion and exclusion criteria:
age range:18 to 65
pass of 3 month of recovery or COVID19
Study aim:
Determining the effect of Covid19 vaccine injection on calprotectin levels in patients (...) severity will be evaluated and compared before and after the injection of the Covid-19 vaccine. These (...) bowel disease are evaluated for calprotectin levels before and after the Covid-19 vaccination.
Main
duration of mechanical ventilation in ICU admitted COVID19 patients
Design:
Permuted block randomization (...) without blinding (phase 1 trial with 33 patients)
Settings and conduct:
66 intubated patients with COVID-19 infection who admitted to the Intensive care unit (Baharloo hospital, Tehran) were randomized to
Study aim:
Evaluation of the effect of using probiotic products to control the symptoms of hospitalized patients with definite diagnosis of COVID-19
Design:
Phase 3 trial, Randomized trial, with block randomization on 60 covid-19 patients, in two groups control and intervention, follow for 14 days.
Settings
Study aim:
evaluation of the effect of treatment regimen contains Intrefron beta-1-b on the Covid19 patients compared with those patients who received treatment regimen without interfron.
Design:
Open label, controlled and paralleled non-randomized clinical trial with control group phase 2-3 on 150
Study aim:
Evaluation of the effect of GCSF injection in treatment of COVID-19 patients with lymphopenia (less than 1000) in Kosar Hospital
Design:
Clinical trial with control group, Randomized, Single (...) /Inclusion and exclusion criteria:
Inclusion criteria: Patients with Covid19; Conscious consent of the
Study aim:
The effectiveness of Cognitive-Behavioral Crisis Intervention Package on COVID-19 Fear Symptoms, Improving Quality of Life and Improving Mental Health in Corona Patients
Design:
Clinical trial with control group
Settings and conduct:
Imam Khomeini, Ziaian and Masih Daneshvari hospitals
reduction of pulmonary complications of COVID-19 in patients
Design:
Clinical trial with control group (...) criteria:
Entry requirements:
Covid19 patients with CT scan confirmation and clinical symptoms
Conditions of non-entry:
Covid19 patients have severe underlying diseases
Intervention groups:
Intervention
Study aim:
Evaluating efficacy and safety of Hydroxychloroquine + Lopinavir or Atazanavir/ritonavir combination in patients with COVID-19
Design:
This is a non-blinded, single group clinical trial.
Settings (...) /Inclusion and exclusion criteria:
Inclusion criteria: Patients with highly suspected or confirmed COVID-19
Study aim:
Evaluating efficacy and safety of interferone β-1a in the treatment COVID-19 infection
Design:
This is a non-blinded randomized clinical trial.
Settings and conduct:
This study will be done (...) criteria:
18-75 years old persons
Highly suspected of confirmed COVID-19 infection
Exclusion criteria
criteria:
18-75 years old persons with highly suspected or confirmed COVID-19
Exclusion criteria (...) Study aim:
Evaluating efficacy and safety of interferone β-1b (IFN β-1b) in the treatment of COVID-19
Design:
This is a non-blinded randomized clinical trial.Included patients will be assigned to
Study aim:
Evaluting the therapeutic and adverse effects of Interferon beta 1-a subcutaneous administration in patients with new Coronavirus (COVID-19)
Design:
Non-controlled clinical trial
Settings and (...) confirmed COVID-19 who are in severe phase and did not have chronic kidney or liver diseases and are not
Study aim:
Determination of the addition of melatonin to routine treatment on treatment outcomes and the quality of sleep in COVID-19 patients
Design:
The present study will be a clinical trial study with a parallel design and without blinding.
Settings and conduct:
The study will be conducted in